BioTech Mag Search: Therapeutics
SoluProt: Prediction of Soluble Protein Expression in Escherichia coli
14 days ago - By Oxford Journals
AbstractMotivationPoor protein solubility hinders the production of many therapeutic and industrially useful proteins. Experimental efforts to increase solubility are plagued by low success rates and often reduce biological activity. Computational prediction of protein expressibility and solubility in Escherichia coli using only sequence information could reduce the cost of experimental studies by enabling prioritisation of highly soluble proteins.ResultsA new tool for sequence-based prediction of soluble protein expression in Escherichia coli, SoluProt, was created using the gradient...
Read more ...Novel ethanol production using biomass preprocessing to increase ethanol yield and reduce overall costs
14 days ago - By Biotechnology for Biofuels
Ethanol biorefineries need to lower their overall production costs to become economically feasible. Two strategies to achieve this are to reduce costs using cheaper feedstocks or to increase the ethanol produc...
Read more ...
Search by Tags
Therapeutics Protein Biology Biologic Biological Computers Industrial Feedstocks Biomass Research
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
PacBio-Powered Analysis Indicates Methylation Makes TB Pathogen So Wily
Scientists have long struggled to explain the success of Mycobacterium tuberculosis in the face of effective therapeutics. Tuberculosis kills more than 1 million people...
Bioinformatics / Software Engineer - Illumina - San Diego, CA
Are you wondering how you can leave your mark and impact the betterment of humanity? Through collaborative innovation, Illumina is fueling groundbreaking...From Illumina - Sat...
Temporary Sr. Research Associate/Research Associate - Ionis Pharmaceuticals...
Ionis was founded in 1989 and was purposely designed to create a better, more efficient drug discovery platform, establish a new innovation-centered business...From Ionis...
Fate Therapeutics, Inc.: Senior Manager / Manager, Regulatory Affairs
Fate Therapeutics, Inc.: Fate Therapeutics is seeking an experienced and highly motivated regulatory professional to support its expanding cellular therapy programs. The...
Lasers and molecular tethers create perfectly patterned platforms for tissue...
Researchers have developed a technique to modify naturally occurring biological polymers with protein-based biochemical messages that affect cell behavior. Their approach uses...
UC San Diego: Director, Clinical Research Operations
UC San Diego: The Alzheimer's Disease Cooperative Study consists of 7 cores, 22 committees, 35 research sites that are members of the... La Jolla, CA ...
Researcher expands plant genome editing with newly engineered variant of...
Alongside Dennis van Engelsdorp, associate professor at the University of Maryland in Entomology named for the fifth year in a row for his work in honey bee and pollinator...
Genetic sequence for parasitic flowering plant Sapria
On January 22 in Current Biology, a team of Harvard-led researchers presented the most complete genome yet assembled of one of the major Rafflesiaceae lineages, Sapria himalayana.
Regulating the ribosomal RNA production line
The enzyme that makes RNA from a DNA template is altered to slow the production of ribosomal RNA , the most abundant type of RNA within cells, when resources are scarce and the...
Identification and Characterization of a Residual Host Cell Protein...
Abstract Host cell proteins are process‐related impurities derived from host organisms, which need to be controlled to ensure adequate product quality and safety. In this...